CRINETICS PHARMACEUTICALS INC. - COMMON STOCK

Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

11 июл 2025 05:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 июл 2025 13:28:57 Источник Nasdaq GlobeNewswire

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline

30 июн 2025 13:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025

16 июн 2025 05:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 июн 2025 13:29:30 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

23 май 2025 05:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 май 2025 13:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

08 май 2025 13:05:02 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

11 апр 2025 05:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 апр 2025 14:04:07 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly

27 мар 2025 13:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 мар 2025 13:36:21 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

27 фев 2025 13:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer

24 фев 2025 05:30:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences

20 фев 2025 13:05:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 фев 2025 13:44:27 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

06 фев 2025 13:35:20 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 янв 2025 14:15:15 Источник Nasdaq GlobeNewswire

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

10 янв 2025 04:00:00 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

06 янв 2025 05:00:00 Источник Nasdaq GlobeNewswire